Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
Iván Mascanfroni(Brigham and Women's Hospital), Francisco J. Quintana(Hospital Prof. Dr. Fernando Fonseca), Jessica E. Kenison(Brigham and Women's Hospital), Leo E. Otterbein(Beth Israel Deaconess Medical Center), Simon C. Robson(Beth Israel Deaconess Medical Center), Ada Yeste(Brigham and Women's Hospital), Maisa C. Takenaka(Brigham and Women's Hospital), Clary B. Clish(Broad Institute), Bonny Patel(Brigham and Women's Hospital), Drew M. Pardoll(Bloomberg (United States)), Avner Priel(University of Alberta), Fan Pan(Nanjing General Hospital of Nanjing Military Command), Yan Wu(Nebraska Medical Center), Shafiuddin Siddiqui(Brigham and Women's Hospital), Alexandre S. Basso(Universidade Federal de São Paulo)
Cited by 446
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k